Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

Oxidative/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis

Azam HosseinzadehRazi Drug Research Center, Iran University of Medical Sciences, Tehran, IranSeyed Ali Javad-MoosaviAir Pollution Research Center, Iran University of Medical Sciences, Tehran, IranRüssel J. ReiterDepartment of Cellular and Structural Biology, UT Health, San Antonio, TX, USARasoul YarahmadiDepartment of Occupational Health, Air Pollution Research Center, Iran University of Medical Sciences, Tehran, IranHabib GhaznaviDepartment of Pharmacology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IranSaeed MehrzadiRazi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran
2018en
ABI

Аннотация

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease associated with disruption of alveolar epithelial cell layer and expansion of fibroblasts/myofibroblasts. Excessive levels of oxidative/nitrosative stress, induction of apoptosis, and insufficient autophagy may be involved in IPF pathogenesis; hence, the targeting of these pathways may ameliorate IPF. Areas covered: We describe the ameliorative effect of melatonin on IPF. We summarize the research on IPF pathogenesis with a focus on oxidative/nitrosative stress, autophagy and apoptosis pathways and discuss the potential effects of melatonin on these pathways. Expert opinion: Oxidative/nitrosative stress, apoptosis and autophagy could be interesting targets for therapeutic intervention in IPF. Melatonin, as a potent antioxidant, induces the expression of antioxidant enzymes, scavenges free radicals and modulates apoptosis and autophagy pathways. The effect of melatonin in the induction of autophagy could be an important mechanism against fibrotic process in IPF lungs. Further clinical studies are necessary to determine if melatonin could be a candidate for treating IPF.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0